ACIU
AC Immune SA
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.02
+0.02 ▲ +0.50%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$3.02
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -0.84 | Insider Own | 38.57% | Shs Outstand | 0.10B | Perf Week | 8.06% |
| Market Cap | 0.30B | Forward P/E | 3.54 | EPS next Y | 345.12% | Insider Trans | - | Shs Float | 0.06B | Perf Month | -0.5% |
| Enterprise Value | 0.19B | PEG | 0.46 | EPS next Q | - | Inst Own | 26.18% | Short Float | 5.46% | Perf Quarter | 8.06% |
| Income | -0.08B | P/S | 69.7 | EPS this Y | 60.95% | Inst Trans | 1.75% | Short Ratio | 9.08 | Perf Half Y | 26.68% |
| Sales | 0.00B | P/B | 5.41 | EPS next 5Y | 7.72% | ROA | -37.64% | Short Interest | 3.32M | Perf YTD | -3.98% |
| Book/sh | 0.56 | P/C | 2.59 | EPS past 3/5Y | 1.71% 1.71% | ROE | -93.71% | 52W High | -24.62% ($4.00) | Perf Year | 31.09% |
| Cash/sh | 1.17 | P/FCF | - | Sales past 3/5Y | 1.45% -23.52% | ROIC | -137.98% | 52W Low | 110.85% ($1.43) | Perf 3Y | 37.67% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -86.1% | Gross Margin | - | Volatility(W/M) | 7.57% 7.24% | Perf 5Y | -61.35% |
| Dividend TTM | - | EV/Sales | 44.08 | Sales Y/Y TTM | -86.41% | Oper. Margin | -1935.02% | ATR (14) | 0.21 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.02 | EPS Q/Q | 1.33% | Profit Margin | -1977.86% | RSI (14) | 52.72 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.02 | Sales Q/Q | -67.36% | SMA20 | 6.55% ($2.83) | Beta | 1.62 | Target Price | $9.09 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 3000000 | SMA50 | -4.37% ($3.16) | Rel Volume | 0.7 | Prev Close | $3 |
| Employees | 122 | LT Debt/Eq | 0.08 | EPS/Sales Surpr. | 2.92% -1.76% | SMA200 | 10.64% ($2.73) | Avg Volume(3M) | 0.37M | Price | $3.02 |
| IPO | 2016/9/23 | Option/Short | Yes/Yes | Trades | 1456 | Volume | 255,657 | Change | 0.5% |
뉴스 로딩 중...